You are here

Surgical Innovation

Surgical Innovation

2018 Impact Factor: 1.472
2018 Ranking: 131/203 in Surgery
Source: Journal Citation Reports (Web of Science Group, 2019)

Editors
Adrian E. Park, MD, FRCSC, FACS, FCS (ECSA) Anne Arundel Health System, Annapolis, MD, USA
Lee Swanstrom, MD Oregon Health and Sciences University; IHU-Strasbourg, USA


eISSN: 15533514 | ISSN: 15533506 | Current volume: 26 | Current issue: 3 Frequency: Bi-monthly

What the surgeon of the future needs to read today…

Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training focuses on the revolution that minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies have brought to the art, science, and business of surgery. This innovative publication prepares both new and experienced surgeons to think and work in "the operating room of the future," while helping them to face the challenges of learning new techniques, understanding and adapting to new technologies, maintaining surgical competencies, and applying surgical outcomes data to their practices.

Each issue of Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training offers unique original articles from the vanguard of clinical practice, noteworthy basic and applied research from the basic sciences, state-of-the-art surgical education, and useful insights into the business of surgical practice. Written by leading international medical and surgical practitioners from specialties such as general surgery, gynecology, urology, cardiothoracic surgery, vascular surgery, head and neck surgery, neurosurgery, otolaryngology, orthopedics, and pediatric surgery, the perceptive and incisive articles highlight those practices and technologies that will change your practice today and revolutionize surgery for decades to come.

Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training covers rapidly emerging topics, often found nowhere else, including:

Clinical Practice

  • New Procedures (for example, NOTES, image guided surgery)
  • New Instruments
  • Practice Management
  • Cross-Specialty Synergies

Research on the Cutting Edge

  • Robotics
  • Energy Sources
  • Operating Room of the Future
  • Materials and Prostheses
  • Biologic Investigations

Surgical Education

  • Surgical Training and Performance Metrics
  • Surgical Simulation
  • Telemedicine
  • Introduction of New Techniques and Technologies into Clinical Practice

Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training is dedicated to becoming the core reference for the most advanced aspects of innovative surgical practice for the most innovative surgeons.

This journal is a member of the Committee on Publication Ethics (COPE)
 

Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training is dedicated to becoming the core reference for the most advanced aspects of innovative surgical practice for the most innovative surgeons. It focuses on the revolution that minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies have brought to the art, science, and business of surgery. Each issue of Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training offers unique original articles from the vanguard of clinical practice, noteworthy basic and applied research from the basic sciences, state-of-the-art surgical education, and useful insights into the business of surgical practice.

Editors
Adrian E. Park, MD Anne Arundel Health System, Annapolis, MD, USA
Lee Swanstrom, MD, FACS, FASGE, FRCSEng(hon)) Oregon Health and Sciences University; IHU-Strasbourg, USA
Editorial Board Members
Mehran Anvari, MD Director Centre for Minimal Access Surgery
Michael Bailey, MD University of Sulley, Guildford, UK
Alfred Cuschieri, MD University of Dundee, UK
Bernard Dallemagne, MD IRCAD, Strasbourg, France
Giovanni Dapri, MD European School of Laparoscopic Surgery, Saint-Pierre University Hospital, Belgium
Ara Darzi, MD St. Mary's Hospital, London, USA
Steve Eubanks, MD Florida Hospital, USA
Abe Fingerhut, MD Centre Hospitalier Intercommunal, Poissy, France
Samuel R. G. Finlayson, MD University of Utah, USA
Gerald M. Fried, MD Montreal General Hospital, Canada
Anthony N. Kalloo, MD Johns Hopkins Hospital, Baltimore, MD, USA
Mousa Khoursheed, BMBCH, FRCS, FACS, FASMBS Kuwait University, Kuwait
Thomas M. Krummel, MD, FACS/FAAP Stanford University, USA
Jacques Marescaux, MD IRCAD, Strasbourg, France
Jeff Marks, MD Case Western University, USA
Ulrich Matern, MD  
Robin McLeod University of Toronto, Canada
Scott Melvin, MD Montefiore Medical Center, Bronx, NY, USA
Jeffrey Ponsky, MD Cleveland Clinic, Cleveland, OH, USA
Todd Ponsky, MD Case Western Reserve University, Cleveland, OH, USA
Dave Rattner, MD Massachusetts General Hospital, USA
Michael Sarr, MD Mayo Medical Center, USA
Steven Schwaitzberg, MD Cambridge Health Alliance, Cambridge, MA, USA
Phil Shauer, MD Cleveland Clinic, USA
Nathaniel J. Soper, MD Northwestern University Feinberg School of Medicine, USA
Amir Szold, MD, FACS Assia Medical Group, Tel Aviv, Israel
Eduardo M. Targarona, MD Hospital de Sant Pau, Spain
Melinda Vassiliou, MD McGill University, Canada
Steven Wexner, MD Cleveland Clinic, Florida, USA
Manabu Yamamoto, MD Adachi Kyosai Hospital, Tokyo, Japan
  • CINAHL
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • EMBASE/Excerpta Medica
  • MEDLINE
  • ProQuest
  • Science Citation Index Expanded (Web of Science)
  • Please read the guidelines below then visit Surgical Innovation (SRI)’s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.

    Only manuscripts of sufficient quality that meet the aims and scope of SRI will be reviewed.

    There are no fees payable to submit or publish in this journal.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that SRI may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper.

     

    1. What do we publish?
    1.1 Aims & Scope
    1.2 Article types
    1.3 Writing your paper

    2. Editorial policies
    2.1 Peer review policy
    2.2 Authorship
    2.3 Acknowledgements
    2.4 Funding
    2.5 Declaration of conflicting interests
    2.6 Research ethics and patient consent
    2.7 Clinical trials
    2.8 Reporting guidelines
    2.9 Research Data

    3. Publishing policies
    3.1 Publication ethics
    3.2 Contributor’s publishing agreement
    3.3 Open access and author archiving

    4. Preparing your manuscript
    4.1 Formatting
    4.2 Artwork, figures and other graphics
    4.3 Supplemental material
    4.4 Reference style
    4.5 English language editing services

    5. Submitting your manuscript
    5.1 ORCID
    5.2 Information required for completing your submission
    5.3 Permissions

    6. On acceptance and publication
    6.1 SAGE Production
    6.2 Online First publication
    6.3 Access to your published article
    6.4 Promoting your article

    7. Further information
    7.1 Appealing the publication decision

     

    1. What do we publish?

    1.1 Aims & Scope
    Before submitting your manuscript to SRI, please ensure you have read the Aims & Scope.

    1.2 Article types
    Acceptable categories for submission include:

    Editorials: Editorials should be brief and to the point, less than 700 words and be cleared by the editors before submission. They have no abstract or key words and less than 10 references.

    Letters to the editor: Letters should be addressed to the editors and can either address a published paper or a surgical opinion. They have no abstract or key words and do not use a structured format. They should be 600 words or less, have a maximum of 5 references and 1 table or figure.

    Original papers: submissions should be less than 5,000 words and be formatted with an abstract, key words and a structured format (background, method, statistics, results, discussion and conclusion). All should include relevant ethical approvals, acknowledgements and conflict of interest statements. Lists of authors in excess of 8 are discouraged and only authors truly involved in the work should be cited.

    They should be assigned to the following categories:

    1. Editorial
    2. Letter to the Editor
    3. History of Innovation
    4. In Context: Review
    5. Innovative Technologies
    6. View from IRCAD
    7. Procedural Innovations
    8. Original Clinical Science
    9. Surgical Education: Training for the Future
    10. Business in Innovation
    11. Frugal Innovation

    Case studies are not routinely accepted in SRI and should only be submitted if they represent an absolutely novel or breakthrough technology or technique.

    1.3 Writing your paper
    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    1.3.1 Make your article discoverable
    For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online

     

    2. Editorial policies

    2.1 Peer review policy
    SRI operates a conventional single-blind reviewing policy in which the reviewer’s name is always concealed from the submitting author.

    As part of the submission process you will be asked to provide the names of two peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below: 

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).

    Please note that the Editors are not obliged to invite/reject any recommended/opposed reviewers to assess your manuscript.

    SRI is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for the journal can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

    2.2 Authorship
    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    1. Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
    2. Drafted the article or revised it critically for important intellectual content,
    3. Approved the version to be published,
    4. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    2.3 Acknowledgements
    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    2.3.1 Writing assistance
    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

    2.4 Funding
    SRI requires all authors to acknowledge their funding in a consistent fashion under a separate heading.  Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    2.5 Declaration of conflicting interests
    It is the policy of SRI to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here

    2.6 Research ethics and patient consent
    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    2.7 Clinical trials
    SRI conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

    2.8 Reporting guidelines
    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives

    The Editors of SRI recommend authors follow the below figure from The IDEAL Framework for Evaluating Surgical Innovation by Dimick et al.


     

    2.9. Research Data
    At SAGE we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, The Journal encourages authors to share their research data in a suitable public repository subject to ethical considerations and where data is included, to add a data accessibility statement in their manuscript file. Authors should also follow data citation principles. For more information please visit the SAGE Author Gateway, which includes information about SAGE’s partnership with the data repository Figshare.

     

    3. Publishing policies

    3.1 Publication ethics
    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway

    3.1.1 Plagiarism
    SRI and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    3.1.2 Prior publication
    If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    3.2 Contributor’s publishing agreement    
    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway

    3.3 Open access and author archiving
    SRI offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

     

    4. Preparing your manuscript for submission

                                                                   

    4.1 Formatting
    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    4.2 Artwork, figures and other graphics
    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines  

    Figures supplied in color will appear in color online regardless of whether or not these illustrations are reproduced in color in the printed version. For specifically requested color reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.

    4.3 Supplemental material
    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files

    4.4 Reference style
    SRI adheres to the AMA Manual of Style. View the guide here to ensure your manuscript conforms to this style.

    4.5 English language editing services
    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

     

    5. Submitting your manuscript
    SRI is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/sri to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    5.1 ORCID
    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

    The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more.

    5.2 Information required for completing your submission
    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    5.3 Permissions
    Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway

     

    6. On acceptance and publication
     

    6.1 SAGE Production
    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorizing the change.

    6.2 Online First publication
    Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.

    6.3 Access to your published article
    SAGE provides authors with online access to their final article.

    6.4 Promoting your article
    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos

     

    7. Further information
    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the SRI editorial office as follows:

    lswanstrom@gmail.com

    7.1 Appealing the publication decision
    Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.

    If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at publication_ethics@sagepub.com

    Individual Subscription, Combined (Print & E-access)


    Hospital Subscription, Combined (Print & E-access)


    Institutional Backfile Purchase, E-access (Content through 1998)


    Institutional Subscription, E-access


    Institutional Subscription, Print Only


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue